Frontiers in Oncology

Establishing Preeminence in Translational Pediatric Oncology: Bass Center Vision 2025

Tanja Gruber, MD, PhD
Tuesday, September 1, 2020

Tanja Gruber, MD, PhD, is the Division Chief of Pediatric Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine and Director of the Bass Center for Cancer and Blood Disorders. She is a product of the University of Washington, with dual BS degrees in Biology and Biochemistry; University of Southern California, there with MD in Medicine and PhD in Immunology; and Children’s Hospital of Los Angeles for Internship and Residency in Pediatrics and then Fellowship in Hematology and Oncology. Dr. Gruber was recruited after fellowship to St. Jude Children’s Research Hospital, where she became a nationally and internationally recognized physician-scientist. At St. Jude she focused on high-risk leukemia and acute megakaryoblastic leukemia (AMKL). Her laboratory research has led to the identification of CBFA2T3-GLIS2, a novel fusion gene that confers a poor prognosis in pediatric AMKL, and a detailed view of the genomic landscape in MLLr leukemia.⁣

Frontiers in Oncology

Frontiers in Oncology, a recurring seminar series organized by the Stanford Cancer Institute, is designed to highlight innovations in cancer research across the spectrum of basic, translational, clinical and population science.  The dynamic speakers represent a broad range of disciplines and expertise from both Stanford faculty and national thought leaders.  The audience for this seminar series includes Stanford faculty, trainees and staff as well as anyone in the broader community with an interest in cancer research.  Each recorded seminar is approximately 1 hour in length.   

Past Seminars